Delivery Order SPE2DR25D2009-SPE2DR26FJ3N1
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.66 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. The award was made on May 16, 2025, with an ultimate completion date of May 19, 2025, utilizing firm fixed-price pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $175,856.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract is scheduled for completion by June 23, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, reflecting...
- The Defense Logistics Agency awarded a $7,966.52 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $18,912.60 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135 DIP 0.5mL, a meningococcal vaccine product. This firm fixed-price contract, with a completion date of June 3, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for $59,655.00 to supply Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The delivery order was competitively awarded with no set-aside designation and carries a firm fixed-price structure, with an ultimate completion date of November 28, 2025. Performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,671.20 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Menveo (meningococcal vaccine) in single-dose vial formulations. This is a firm fixed-price, competitively awarded contract with performance completion targeted for December 18, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition....
- The Defense Logistics Agency awarded a $1,626.27 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine, with performance in Conshohocken, Pennsylvania and a completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply relationships with the Defense Logistics...
- The Defense Logistics Agency awarded a $14,858.01 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $165,523.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside and competitively awarded, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3N1Delivery Order
The Defense Logistics Agency awarded a $146,369.15 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML meningococcal vaccine, with an ultimate completion date of November 26, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies essential medical commodities to support military healthcare programs globally, including vaccines, medications, and medical supplies across multiple therapeutic domains. The company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle. The Menveo vaccine delivery under this order supports the Department of Defense's medical supply chain requirements for meningococcal disease prevention across military personnel and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $146.4k | 11/24/25 |